Close Menu

lawsuit

NEW YORK (GenomeWeb News) — Illumina has countersued Intelligent Bio-Systems and Qiagen, claiming they infringe several of its sequencing-related patents, the company said today.

The University of Utah this month took steps to keep its RNAi intellectual property lawsuit on track after the defendants in the case sought a stay of proceedings, arguing that discovery in the litigation should proceed while certain jurisdictional issues are resolved.

The story has been updated to include comments by Sequenom.
NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that Sequenom's motion for a preliminary injunction against it has been denied by a federal court.

Roughly one week after a US District Court rejected the efforts of University of Massachusetts officials to have an intellectual property lawsuit filed against them dismissed, the UMass defendants have filed an appeal with a federal court to re-examine the issue.

NEW YORK (GenomeWeb News) – Illumina today said that it has filed a second patent infringement suit against Complete Genomics, following an earlier patent suit in 2010.

A Massachusetts District Court this week denied motions to dismiss an intellectual property-ownership lawsuit filed by the University of Utah against Alnylam Pharmaceuticals and several University of Massachusetts officials, among others, telling the defendants that they have not

Galena Biopharma, the former parent firm of RXi Pharmaceuticals, has settled four lawsuits filed by investor groups that had raised questions about its now-completed spinout of the RNAi drug developer.

Tekmira Pharmaceuticals' CEO this week provided an update on the company's ongoing litigation with partner Alnylam Pharmaceuticals, confirming that a roughly one-year-old technology-misappropriation lawsuit could be resolved before the end of 2012.

The University of Utah last week fired back at a bid by University of Massachusetts officials to have an RNAi technology intellectual property lawsuit dismissed, arguing that the court hearing the case — and not the US Supreme Court, as the officials contend — is the appropriate

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement and licensing agreement with GeneSeek, resolving a patent dispute between the firms.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.